MEI XIANG

Meiwu Technology, a name once fading in the market, has caught attention this week as its shares climb noticeably. While the Nasdaq rose 1. 24 % and the S&P 500 added 0. 83 %, Meiwu’s price jump stands out among the chatter. The buzz around the company stems from a recent private placement that inj

Meibomian gland dysfunction and its structural complications are becoming an increasing issue among young medical trainees. These conditions can be somewhat worrying for those just starting their careers. Scientists want to understand why this is happening more frequently in young adults beginning t